Senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents, but compensating for this by overproducing a protective protein, GPX4, which staves off death.

Scientists have pinpointed a mechanism that may explain heart cancer's rarity and point to new cancer treatments.

Scientists have captured the most detailed structural images to date of a specific type of protein's DNA repair process, a ...

Scientists have uncovered an unexpected way cells can generate cancer-driving proteins—by cutting RNA into shorter, ...

Scientists have captured the most detailed structural images to date of a specific type of protein's DNA repair process, a ...

Imagine that two women have breast cancer with the same subtype: hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-). They’re the same age, weight, and height ...

Can WuXi AppTec’s Integrated Discovery Platform Power Oncology? WuXi AppTec’s integrated platform combines high-authority screening, pharmacology, and early assessment in a single end-to-end system.

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments ...

Chemotherapy, anti-cancer drugs that stop the growth of tumor cells, encompasses a wide variety of different agents. Some chemotherapeutic agents work by directly killing cancer cells, while others ...

A research team from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), ...